Treatment of xerostomia: a double-blind trial in 108 patients with Sjögren's syndrome. 1981

A C Klestov, and J Webb, and D Latt, and G Schiller, and K McNamara, and D Y Young, and J Hobbes, and J Fetherston

The first-ever controlled study of a therapeutic modality for xerostomia is reported. A recently described formulation for saliva substitute (SS) has been tested against a glycerine mouthwash as a control saliva substitute (placebo) in a double-blind clinical trial in 108 patients with varying grades of xerostomia of Sjögren's syndrome. The results indicate that SS offered significant relief of nocturnal oral discomfort (p less than 0.02) and more patients reported "excellent" improvement (p less than 0.01) on a five-point graded response. In all other respects, the SS was not significantly better than the placebo. Significant adverse effects were not reported. It is suggested that any such current and future therapeutic modalities for Sjögren's syndrome be subjected to similar critical appraisal of their worth.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009067 Mouthwashes Solutions for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. (From Boucher's Clinical Dental Terminology, 4th ed) Mouth Bath,Mouth Rinse,Mouth Wash,Bath, Mouth,Baths, Mouth,Mouth Baths,Mouth Rinses,Rinse, Mouth,Rinses, Mouth,Wash, Mouth
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D005990 Glycerol A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism. It is used as a solvent, emollient, pharmaceutical agent, or sweetening agent. 1,2,3-Propanetriol,Glycerin,1,2,3-Trihydroxypropane,Glycerine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012463 Saliva The clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin. Salivas

Related Publications

A C Klestov, and J Webb, and D Latt, and G Schiller, and K McNamara, and D Y Young, and J Hobbes, and J Fetherston
January 1982, Scandinavian journal of rheumatology,
A C Klestov, and J Webb, and D Latt, and G Schiller, and K McNamara, and D Y Young, and J Hobbes, and J Fetherston
October 2006, Journal of the Formosan Medical Association = Taiwan yi zhi,
A C Klestov, and J Webb, and D Latt, and G Schiller, and K McNamara, and D Y Young, and J Hobbes, and J Fetherston
March 2002, Arthritis and rheumatism,
A C Klestov, and J Webb, and D Latt, and G Schiller, and K McNamara, and D Y Young, and J Hobbes, and J Fetherston
January 1986, Scandinavian journal of rheumatology. Supplement,
A C Klestov, and J Webb, and D Latt, and G Schiller, and K McNamara, and D Y Young, and J Hobbes, and J Fetherston
May 1993, Annals of the rheumatic diseases,
A C Klestov, and J Webb, and D Latt, and G Schiller, and K McNamara, and D Y Young, and J Hobbes, and J Fetherston
September 2002, Clinical drug investigation,
A C Klestov, and J Webb, and D Latt, and G Schiller, and K McNamara, and D Y Young, and J Hobbes, and J Fetherston
May 1998, The Journal of rheumatology,
A C Klestov, and J Webb, and D Latt, and G Schiller, and K McNamara, and D Y Young, and J Hobbes, and J Fetherston
April 2010, Arthritis and rheumatism,
A C Klestov, and J Webb, and D Latt, and G Schiller, and K McNamara, and D Y Young, and J Hobbes, and J Fetherston
June 2004, Annals of the rheumatic diseases,
A C Klestov, and J Webb, and D Latt, and G Schiller, and K McNamara, and D Y Young, and J Hobbes, and J Fetherston
January 1996, Arthritis and rheumatism,
Copied contents to your clipboard!